Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Opin Pharmacol ; 37: 10-15, 2017 12.
Article in English | MEDLINE | ID: mdl-28802873

ABSTRACT

Gut hormones have long been understood to regulate food intake and metabolism. Bariatric surgery significantly elevates circulating gut hormone levels and is proven to affect acute remission of type 2 diabetes before any weight loss is observed. Subsequent weight loss is accrued over weeks to months but is sustained into the long term. Hence, there exists great enthusiasm to recapitulate these changes in gut hormones in the form of novel combination drugs for type 2 diabetes and obesity.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Gastrointestinal Tract/metabolism , Obesity/drug therapy , Animals , Cholecystokinin/metabolism , Diabetes Mellitus, Type 2/metabolism , Gastric Inhibitory Polypeptide/metabolism , Glucagon-Like Peptide 1/agonists , Glucagon-Like Peptide 1/metabolism , Humans , Obesity/metabolism , Oxyntomodulin/pharmacology , Peptide YY/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...